Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.
\